Estrogens, Conjugated (USP)
Definition
Estrogens, Conjugated (USP): A pharmaceutical preparation containing a mixture of water-soluble, conjugated estrogens derived wholly or in part from URINE of pregnant mares or synthetically from ESTRONE and EQUILIN. It contains a sodium-salt mixture of ESTRONE sulfate (52-62%) and EQUILIN sulfate (22-30%) with a total of the two between 80-88%. Other concomitant conjugates include 17-alpha-dihydroEQUILIN, 17-alpha-estradiol, and 17-beta-dihydroEQUILIN. The potency of the preparation is expressed in terms of an equivalent quantity of sodium ESTRONE sulfate.
Annotations
do not confuse with ESTRADIOL CONGENERS
Other Entries
Estrogenic Substances, Conjugated
ASTA Medica Brand of Estrogens, Conjugated
Almirall Brand of Estrogens, Conjugated
Carentil
Climarest
Climopax
Congest
Conjugated Equine Estrogens
Conjugated Estrogens
Dagynil
Estro-Feminal
Estrogenic Hormones, Conjugated
Estrogens, Conjugated
Femavit
Mack Brand of Estrogens, Conjugated (USP)
Major Brand of Estrogens, Conjugated (USP)
Oestro-Feminal
Oestrofeminal
Pasadena Brand of Estrogens, Conjugated (USP)
Pharmacia Brand of Estrogens, Conjugated (USP)
Prelestrin
Premarin
Presomen
Progens
Solvay Brand of Estrogens, Conjugated
Transannon
Trianon Brand of Estrogens, Conjugated
Wyeth Brand of Estrogens, Conjugated
Conjugated Estrogenic Hormones
Conjugated Estrogenic Substances
Equine Estrogens, Conjugated
Pharmacy Actions
Allowable Qualifiers
administration & dosage adverse effects agonists analysis antagonists & inhibitors blood cerebrospinal fluid chemical synthesis chemistry classification contraindications diagnostic use economics history immunology isolation & purification metabolism pharmacokinetics pharmacology poisoning radiation effects standards supply & distribution therapeutic use toxicity urine
Categories
Entry Date
01-01-1999
Common Chronic Illnesses
Coronary Disease
An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
Diabetes Mellitus, Type 1
A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
Diabetes Supplies | Diabetic Groups
Diabetes Mellitus, Type 2
A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
Free Diabetes Supplies
Hypertension
Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
Mesothelioma
A tumor derived from mesothelial tissue (peritoneum, pleura, pericardium). It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. (Dorland, 27th ed)
Osteoarthritis
A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.
